Regulatory actions for Jan. 29, 2026 Jan. 29, 2026 Regulatory snapshots, including global drug submissions and approvals, and other regulatory decisions and designations: Biogen, Drug Farm, Glaukos, Guerbet, Immix , Johnson & Johnson, Shorla.Read More
Other news to note for Jan. 29, 2026 Jan. 29, 2026 Biopharma happenings, including deals and partnerships, and other news in brief: Applied, Cycle, EMS, Hanmi, Idorsia, Laboratorios Sanfer.Read More
In the clinic for Jan. 29, 2026 Jan. 29, 2026 Clinical updates, including data readouts and publications: Boehringer Ingelheim, Calcimedica, GRI Bio, PDS, Poolbeg, Regenxbio.Read More
Financings for Jan. 29, 2026 Jan. 29, 2026 Biopharmas raising money in public or private financings, including: Altimmune, Biomind, Elysium, Enveric, Rakovina, Sensorion, Stellular.Read More
Appointments and advancements for Jan. 29, 2026 Jan. 29, 2026 New hires and promotions in the biopharma industry, including: Biontech, Convergent, Omass, Pacira, Rakovina, Rani, Taiho, Vera.Read More
Appointments and advancements for Jan. 29, 2026 Jan. 29, 2026 New hires and promotions in the med-tech industry, including: Jenavalve, Opentrons, Vicentra.Read More
Financings for Jan. 29, 2026 Jan. 29, 2026 Med-tech firms raising money in public or private financings, including: Essity, Invo Fertility, Prenosis.Read More
In the clinic for Jan. 29, 2026 Jan. 29, 2026 Clinical updates, including trial initiations, enrollment status and data readouts and publications: Eko Health.Read More